To learn more, please call our Research Department at (513) 936-5388 or (888) 649-4800. Or email abradley@ohcmail.com
- DIFFUSE LARGE CELL
- FIRST LINE
- Study number:
- LYM 67 CO5013 Millenium Pharmceuticals, Inc.
- Protocol title:
- An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell Like Diffuse Large B-Cell Lymphoma
- Status:
- Open